[1]
Pingyang Han et al. 2023. Risk of Hepatitis B Virus Reactivation in Patients with Resolved Infection on Therapy with Corticosteroids and Conventional Synthesis Immunosuppressants for Kidney Disease: A Single-Center Analysis of 258 Patients. Turkish Journal of Gastroenterology. 34, 10 (Aug. 2023), 1035–1040.